Tag

Medicines

High Level Dialogue TRIPS Waiver: If Not Now, Then When?

Report Big Pharma takes it all

Patent abuse, lack of transparency, profiteering How Covid-19 exposes Big Pharma’s harmful business strategies

9 March 2021

Affordable drugs How dare you, Novartis?

28 February 2020

Victory for public health Novartis drops the Kymriah patent that was opposed by Public Eye

16 December 2019

Affordable drugs Novartis cancer treatment for CHF 370,000?! Public Eye opposes Kymriah patent

3 July 2019

Report Post-Trial Access to Swiss Medicines

Clinical trials Roche and Novartis neglect their ethical responsibility in emerging countries

20 May 2019

Panel discussion No fair pricing without transparency

11 April 2019

News Stop TRIPS-plus measures in trade agreement with Indonesia

6 November 2018